Pharmacological inhibition of glycogen phosphorylase (GP) lowers plasma glucose in rat models of type 2 diabetes

被引：0
|
作者：
Turnbull, A
Fraser, J
Loxham, S
Teague, J
Ellershaw, L
Roberts, D
Mayers, R
Walker, M
Evans, J
Freeman, S
Poucher, S
Carey, F
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A343 / A343
页数：1
相关论文
共 50 条
  • [1] Hepatic glucose metabolism following inhibition of glycogen phosphorylase in the high fat fed rat model of type 2 diabetes
    Fosgerau, K
    Rakipovski, G
    Petersen, H
    Pedersen, KE
    Larsen, MO
    DIABETES, 2004, 53 : A575 - A575
  • [2] Harunganin lowers glucose and triglyceride concentrations in mouse and rat models of type 2 diabetes
    Reed, MJ
    Meszaros, K
    Luo, J
    Carlson, TJ
    King, SR
    Inman, W
    Rao, K
    Entes, LJ
    Claypool, MD
    Brignetti, D
    Scribner, KA
    Gadbois, TM
    DIABETES, 1999, 48 : A110 - A111
  • [3] Glycogen phosphorylase inhibition in type 2 diabetes therapy - A systematic evaluation of metabolic and functional effects in rat skeletal muscle
    Baker, DJ
    Timmons, JA
    Greenhaff, PL
    DIABETES, 2005, 54 (08) : 2453 - 2459
  • [4] Inhibition of liver glycogen phosphorylase expression using an antisense oligonucleotide lowers blood glucose levels in diabetic mice
    Butler, M
    Valley, R
    Watts, LM
    Murray, SF
    Booten, S
    Monia, BP
    Michael, MD
    Sloop, KW
    Taylor, SI
    Bhanot, S
    DIABETES, 2002, 51 : A43 - A43
  • [5] Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus
    Treadway, JL
    Mendys, P
    Hoover, DJ
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (03) : 439 - 454
  • [6] Glycogen phosphorylase as a molecular target for type 2 diabetes therapy
    Oikonomakos, NG
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2002, 3 (06) : 561 - 586
  • [7] GLUCOSE AS A REGULATOR OF GLYCOGEN PHOSPHORYLASE IN RAT DIAPHRAGM .2. EFFECT OF GLUCOSE AND RELATED COMPOUNDS ON PHOSPHORYLASE PHOSPHATASE
    HOLMES, PA
    MANSOUR, TE
    BIOCHIMICA ET BIOPHYSICA ACTA, 1968, 156 (02) : 275 - &
  • [8] Inhibition of Glycogen Phosphorylase in the Context of Type 2 Diabetes, with Focus on Recent Inhibitors Bound at the Active Site
    Praly, J. -P.
    Vidal, S.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (12) : 1102 - 1126
  • [9] Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition
    Goyard, David
    Konya, Balint
    Chajistamatiou, Aikaterini S.
    Chrysina, Evangelia D.
    Leroy, Jeremy
    Balzarin, Sophie
    Tournier, Michel
    Tousch, Didier
    Petit, Pierre
    Duret, Cedric
    Maurel, Patrick
    Somsak, Laszlo
    Docsa, Tibor
    Gergely, Pal
    Praly, Jean-Pierre
    Azay-Milhau, Jacqueline
    Vidal, Sebastien
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 108 : 444 - 454
  • [10] Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors
    Sipos, Adam
    Szennyes, Eszter
    Hajnal, Nikolett Eva
    Kun, Sandor
    Szabo, Katalin E.
    Uray, Karen
    Somsak, Laszlo
    Docsa, Tibor
    Bokor, Eva
    PHARMACEUTICALS, 2021, 14 (04)
12345